Report Highlights
The global market for validation, calibration and standardization in the global life sciences should grow from $1.5 billion in 2018 to reach $2.1 billion by 2023 at a compound annual growth rate (CAGR) of 6.7% for the period of 2018-2023.
Report Includes
- 85 data tables and 50 additional tables
- Country specific data and analysis for US, Canada, Germany, France, UK, Spain, China, India, Japan, and Australia
- Explanation of validation and calibration of instruments such as heap filters, pH meters, incubators, autoclaves, HPLC units, and GC units
- Discussion of ongoing research in treatments of various diseases and susceptibility of various microbes toward traditional medicines as driving factors to the industry
- Insight into the regulatory compliances in life science industry
- Detailed profile of major companies of the industry, including Beckman Coulter, Inc., Biovia (Dassault Systems), Data Sciences International (DSI), IBM and Thermo Fisher Scientific
Report Scope
The scope of this report is broad and covers multiple types of services available, instruments and consumables utilized, ongoing research and development in global validation, calibration and standardization in life sciences market and potential end-users. Global validation, calibration and standardization in the life sciences market is broken down into instruments and consumables, service type, service providers and end users. Revenue forecasts from 2017 to 2023 are given for each of these four segments, with estimated values derived from the total revenues of companies operating in the market.
The report includes a discussion of the major players across each region in validation, calibration and standardization in the life sciences market. This report also explains the major drivers and regional dynamics of this market and current trends within the industry.
The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors in this market.
Analyst Credentials
Sathya Durga has more than 10 years of experience in healthcare and biotechnology research. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She holds an MBA in marketing and finance from Chennai University and has worked with major market research firms.
Sathya Durga has authored several market research studies on subjects in the healthcare domain, including:
- Healthcare tracking technologies.
- Molecular diagnostics market.
- High-growth markets in healthcare and life sciences.
- Adoption rates and analysis of over-the-counter (OTC) diabetic medicines and supplements.
- Radio frequency identification (RFID), real-time locating systems (RTLS), internet protocol (IP) surveillance, and other emerging technologies in the healthcare domain.
a
Related Reports
Analytical Laboratory Instruments Manufacturing: Global Markets
The global market for analytical laboratory instruments is estimated to increase from $60.9 billion in 2023 to reach $82.5 billion by 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 through 2028.
Biosensors and Nanosensors: Global Markets and Technologies
The global market for biosensors and nanosensors is expected to grow from $30.6 billion in 2023 to $43.5 billion by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2028.
Biologics Development and Manufacturing Testing: Technologies and Global Markets
The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies in biopharmaceutical manufacturing should grow from $4.3 billion in 2021 to $7.3 billion by 2026 with a compound annual growth rate (CAGR) of 11.3% for the period of 2021-2026.
Recent Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
RNAi Technologies and Global Markets
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
Metabolomics: Technologies and Global Markets
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
Global Recombinant Proteins Market
The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More